Electrochemical investigations of [bis(triphenylphosphoranylidene)ammonium)][tris(2-(diphenylphosphino)thiaphenolato)ruthenate(II)], PPN[Ru(DPPBT)(3)] (1), and [(bis(2-(diphenylphosphino)thiaphenolato)methane)(2-(diphenylphosphino)thiaphenolato)ruthenium(II)] chloride, [Ru((DPPBT)(2)CH(2))(DPPBT)]Cl (2) are reported. Complex 1 is oxidized reversibly in a metal-centered event by one electron at a potential of +455 mV (vs Ag/AgCl) to the ruthenium(III) derivative [tris(2-(diphenylphosphino)thiaphenolato)ruthenium(III)], 3. Complex 3 can also be prepared by iodine oxidation of 1 in acetonitrile. Oxidation of 3 in acetonitrile is reversible on a cyclic voltammetry time scale but irreversible upon bulk oxidation yielding Ru-X. Monitoring the oxidation of 3 by UV-visible spectroscopy reveals a proposed metal-coordinated thiyl radical intermediate with a maximum absorbance at 850 nm. This intermediate decays at a temperature of -20 degrees C with a rate constant of (5.82 +/- 0.73) x 10(-)(3) s(-)(1) with a small, positive deltaH and a large, negative deltaS. Ru-X can be oxidized reversibly to Ru-Y at a potential of +806 mV but cannot be reduced. Complex 2 is reversibly oxidized by one electron in a metal-centered event to 4 at a potential of +767 mV.
No takes yet. Share an insight, caveat, or question.
Grapperhaus et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: